EVH

Evolent Health, Inc.

Healthcare · $467M market cap

Verdict

We can't put a fair value on EVH right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-9.0% a year✗
Sales growth28.5% a year✓
Free cash flow growth—?
Return on invested capital-1.4%✗

Follow EVH

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

2 of the investors we track hold EVH. In Q2 2026, 1 sold out. Who we track

Moves in Q2 2026

Sold out: Lee Ainslie

About Evolent Health, Inc.

Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both…

Medical - Healthcare Information Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works